Effectiveness and safety of AI-driven closed-loop systems in diabetes management: a systematic review and meta-analysis
Guardado en:
| Publicado en: | Diabetology & Metabolic Syndrome vol. 17 (2025), p. 1-13 |
|---|---|
| Autor principal: | |
| Otros Autores: | , , , , , , , , |
| Publicado: |
Springer Nature B.V.
|
| Materias: | |
| Acceso en línea: | Citation/Abstract Full Text Full Text - PDF |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| Resumen: | BackgroundDiabetes is a metabolic disease that can lead to severe cardiovascular diseases and neuropathy. The associated medical costs and complications make timely and effective management particularly important. Traditional diagnostic and management methods, like frequent glucose sampling and insulin injections, impose physical injuries on subjects. The development of artificial intelligence (AI) has opened new opportunities for diabetes management.MethodsWe conducted a meta-analysis integrating existing research, identifying a total of 1156 subjects to assess the effectiveness and safety of AI-based wearable devices, specifically closed-loop insulin delivery systems, in diabetes treatment.ResultsCompared to standard controls, AI-based closed-loop systems can analyze glucose data in real-time and automatically adjust insulin delivery, resulting in reduced time outside target glucose ranges (SMD = 0.90, 95% CI = 0.69 to 1.10, I2 = 58%, P < 0.001).ConclusionAI-based closed-loop systems enhance the precision and convenience of diabetes treatment. This meta-analysis providing essential references for clinical treatment and policymaking in diabetes care. |
|---|---|
| ISSN: | 1758-5996 |
| DOI: | 10.1186/s13098-025-01819-0 |
| Fuente: | Health & Medical Collection |